{"id":650047,"date":"2023-05-02T17:14:01","date_gmt":"2023-05-02T17:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=650047"},"modified":"2023-05-02T17:14:01","modified_gmt":"2023-05-02T17:14:01","slug":"major-depressive-disorder-market-analysis-market-size-epidemiology-leading-companies-companies-sage-therapeutics-jj-minerva-neurosciences-relmada-therapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/major-depressive-disorder-market-analysis-market-size-epidemiology-leading-companies-companies-sage-therapeutics-jj-minerva-neurosciences-relmada-therapeutics_650047.html","title":{"rendered":"Major Depressive Disorder Market Analysis, Market Size, Epidemiology, Leading Companies | Companies – SAGE Therapeutics, J&J, Minerva Neurosciences, Relmada Therapeutics"},"content":{"rendered":"
\n
\"Major<\/a><\/div>\n
\n
Major Depressive Disorder Market<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Major Depressive Disorder – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Major Depressive Disorder, historical and forecasted epidemiology as well as the Major Depressive Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight has launched a new report on “Major Depressive Disorder – Market Insights, Epidemiology, and Market Forecast-2032”.<\/p>\n

DelveInsight’s “Major Depressive Disorder – Market Insights, Epidemiology, and Market Forecast-2032″<\/a> report delivers an in-depth understanding of the Major Depressive Disorder, historical and forecasted epidemiology as well as the  Major Depressive Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Major Depressive Disorder Market Report<\/a>:<\/p>\n

    \n
  1. According to the association, around 17.3 million aged 18 years or older in the U.S. had experienced at least one major depressive episode in the last year, which represented 6.7% of all American adults. While the major depressive disorder can develop at any age, the median age at onset is 32.5 years old.<\/li>\n
  2. According to the association, the prevalence of major depressive episodes was higher among adult females (8.7%) compared to males (5.3%). The prevalence of adults with a major depressive episode was highest among individuals aged 18-25 (13.1%).<\/li>\n<\/ol>\n

    Key benefits of the report:<\/p>\n

      \n
    1. Major Depressive Disorder market report covers a descriptive overview and comprehensive insight of the Major Depressive Disorder Epidemiology and Major Depressive Disorder market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/li>\n
    2. The Major Depressive Disorder market report provides insights on the current and emerging therapies.<\/li>\n
    3. Major Depressive Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n
    4. The Major Depressive Disorder market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Major Depressive Disorder market.<\/li>\n<\/ol>\n

      Got queries? Click here to know more about the Major Depressive Disorder Market Landscape<\/a>.<\/p>\n

      Major Depressive Disorder Overview<\/p>\n

      Sadness is a natural part of the human experience. These feelings are normally short-lived. When someone experiences persistent and intense feelings of sadness for extended periods of time, then they may have a mood disorder such as major depressive disorder.<\/p>\n

      MDD, also referred to as clinical depression, is a significant medical condition that can affect many areas of your life. It impacts mood and behaviour as well as various physical functions, such as appetite and sleep.<\/p>\n

      The key players involved in the Major Depressive Disorder market<\/a>:<\/p>\n